AuntMinnie 2007: Gadolinium: A 'necessary factor' in the development of NSF?
AuntMinnie
AUGUST 5, 2024
The FDA's first advisory in early 2006 stated that "worldwide, there are approximately 200 reports of NSF," with a December update of "90 patients with moderate to end-stage kidney disease who developed NSF after they had an MRI or MRA with a gadolinium-based contrast agent." Nephrogenic Fibrosing Dermopathy [NFD/NSF Web site].
116 
Let's personalize your content